IDEAYA Biosciences Inc (IDYA)
41.53
-0.91
(-2.14%)
USD |
NASDAQ |
May 16, 16:00
41.55
+0.02
(+0.05%)
After-Hours: 20:00
IDEAYA Biosciences Shareholders Equity (Quarterly): 935.31M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 935.31M |
| December 31, 2023 | 621.09M |
| September 30, 2023 | 508.05M |
| June 30, 2023 | 501.61M |
| March 31, 2023 | 333.81M |
| December 31, 2022 | 349.46M |
| September 30, 2022 | 368.77M |
| June 30, 2022 | 269.32M |
| March 31, 2022 | 288.67M |
| December 31, 2021 | 301.51M |
| September 30, 2021 | 317.63M |
| Date | Value |
|---|---|
| June 30, 2021 | 240.26M |
| March 31, 2021 | 233.13M |
| December 31, 2020 | 198.27M |
| September 30, 2020 | 195.43M |
| June 30, 2020 | 172.06M |
| March 31, 2020 | 89.10M |
| December 31, 2019 | 100.40M |
| September 30, 2019 | 110.41M |
| June 30, 2019 | 120.61M |
| March 31, 2019 | 80.33M |
| December 31, 2018 | -48.95M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
89.10M
Minimum
Mar 2020
935.31M
Maximum
Mar 2024
312.74M
Average
278.99M
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co Inc | 40.36B |
| Pfizer Inc | 92.28B |
| Geron Corp | 344.87M |
| Verastem Inc | 46.22M |
| Karyopharm Therapeutics Inc | -168.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 961.53M |
| Total Liabilities (Quarterly) | 26.22M |